Updated: Jul 19, 2024
The average Intra-Cellular Therapies stock price target is 97.45 with a max estimate of 120.00 and a min estimate of 77.00
Review Intra-Cellular Therapies earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Jul 19, 2024